Partner Therapeutics
biotechnology company
Based in MA
AI Overview
With $810K in lobbying spend across 19 quarterly filings, Partner Therapeutics is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $90K |
| 2022 | $180K |
| 2023 | $180K |
| 2024 | $180K |
| 2025 | $180K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Partner Therapeutics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations
Issues pertaining to the development of public health emergency medical countermeasures.
Issues pertaining to the development of public health emergency medical countermeasures within the FY22 Labor, HHS, Education and Related Agencies bills.
Issues pertaining to the development of public health emergency medical countermeasures, Strategic National Stockpile, BARDA and the ASPR.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.